Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine
BioImpacts · 30.11.2025 · 15 · 32645
DOI: 10.34172/bi.32645 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioImpacts, online erschienen am 30.11.2025. Verfasst von Behrouz Seyfinejad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Metoprolol is therapeutically formulated as a racemate with stereoselective pharmacokinetics influenced by CYP2D6 polymorphism. Understanding enantioselective disposition is critical for optimizing therapy in hypertensive patients, particularly during long-term treatment, where metabolic and excretory pathways may interact unpredictably.
Methods
This study analyzed plasma samples from 18 hypertensive patients on long-term metoprolol therapy using a validated chiral capillary electrophoresis method. Enantiomer concentrations were quantified, and S/R ratios were evaluated alongside patient demographics, dosing regimens, and co-administered drugs. The study design focused on identifying deviations from expected enantiomeric patterns observed in single-dose or short-term multi-dose administration in healthy individuals studies.
Results
While most patients (70%) exhibited the anticipated S/R ratio≥1, 30% demonstrated inverted plasma S/R ratios (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
- Pharmaceutical Analysis Research Center, Pharmaceutical Sciences Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
- Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- Endocrine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Behrouz Seyfinejad, Kimiya Jouyban, Abolghasem Jouyban
Zitieren
APA
Seyfinejad, B., Jouyban, K., Houshyar, J., Jabbaripour Sarmadian, A., & Jouyban, A. (2025). Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine. BioImpacts, 15, 32645. https://doi.org/10.34172/bi.32645
Vancouver
Seyfinejad B, Jouyban K, Houshyar J, Jabbaripour Sarmadian A, Jouyban A. Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine. BioImpacts. 2025;15:32645. doi:10.34172/bi.32645
BibTeX
@article{Seyfinejad2025,
author = {Seyfinejad, Behrouz and Jouyban, Kimiya and Houshyar, Jalil and Jabbaripour Sarmadian, Amirreza and Jouyban, Abolghasem},
title = {Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine},
journal = {BioImpacts},
year = {2025},
volume = {15},
pages = {32645},
doi = {10.34172/bi.32645}
}
EUVIMED